Hi zmans ,
I thought Phillip said that, if there is to be a deal with Philips, the intention is to start small with a few trial hospitals in Australia and Europe?
Did I get that wrong?
The Intellispace Cognition technology Philips Chief Innovations Officer, Jeroen Tas, was saying Philips was working on back in March (which has application for dementia diagnosis) was only launched a month ago, and is currently commercially available only in the US .
https://www.globenewswire.com/news-...r-aiding-cognitive-assessment-in-the-U-S.html
That’s exactly nine months from the first mention I can find on it, to the launch to a selected market?
I am not saying that by next November Painchek won’t be fully entrenched in Philips hospital technology, I just think that even if it is, the roll out may take a bit longer.
The FDA approval might not even be through yet so American hospitals won’t be able to use it?
Hi zmans , I thought Phillip said that, if there is to be a deal...
-
- There are more pages in this discussion • 11,831 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.002(5.88%) |
Mkt cap ! $52.34M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.1¢ | $9.469K | 294.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 111485 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 15.57pm 12/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |